Is Premarin more natural than bioidentical estrogen?

This is one of the clearest examples of how natural fails as a useful category here.

Conjugated equine estrogens, the ingredient in Premarin, is not a single molecule; it is a standardized mixture extracted from pregnant mares' urine, containing at least ten conjugated estrogens, including equine estrogens that have no counterpart in human biology at all. Bioidentical estradiol, by contrast, is lab-synthesized to be chemically identical to what a human ovary makes, but it is manufactured in a laboratory rather than harvested from a living source. So under the everyday meaning of natural, the horse-derived extract has the better claim to the word, and the lab-made bioidentical molecule does not, which is the opposite of how the two are usually marketed.

What to know about this answer

There isn't real scientific disagreement about what conjugated equine estrogens is made of; the interesting tension is entirely about language, whether natural should be applied to the horse-derived extract, the lab-made bioidentical molecule, neither, or both.

What the research shows, and which source each finding rests on

Conjugated equine estrogens is not a single molecule; it is a biological extract from pregnant mares' urine, standardized to a defined mixture of at least ten conjugated estrogen sulfates, with equilin and its derivatives being equine estrogens that have no human physiological counterpart

E [1]

17-beta estradiol is manufactured semi-synthetically in a laboratory, typically starting from a plant compound extracted from soy or yam and chemically converted through several steps; it is not extracted from a plant in usable form

E [2]

After more than 20 years of follow-up in WHI, conjugated equine estrogens alone, without a progestin, were associated with significantly lower breast cancer incidence and mortality than placebo, while conjugated equine estrogens plus medroxyprogesterone acetate were associated with higher incidence; this is the finding that most cleanly separates the effect of the estrogen from the added progestin, though the two WHI arms differed in population as well and were not randomized against each other

B [3]

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Natural should track literal biological origin

The everyday meaning of the word, as one clinician deliberately points out to make a rhetorical point

Under the ordinary meaning of natural, the extract taken directly from a living animal's urine has a stronger claim to the word than a molecule built up through several chemical synthesis steps in a laboratory, even though that lab-made molecule matches human physiology more closely.

E [1]

Natural should track structural identity to human biology instead

The more common popular usage, which is not coherent as a safety claim

Most people use natural to mean like what my body makes, which favors bioidentical estradiol; but the broader point is that neither reading tells you anything about safety, since the body's own endogenous estrogen exposure is itself the best-established modifiable risk factor for hormone-receptor-positive breast cancer. A molecule being either horse-derived or human-identical says nothing on its own about risk.

E [2]

What would settle it: This is a definitional and communication question rather than an evidence question; the practical resolution is to stop leaning on natural at all and instead specify the molecule and its actual trial evidence.

What is really going on here

Is a natural claim being used to imply safety, when structure alone doesn't determine safety?
Does the estrogen product I'm considering come from a mare-urine extract or from lab-synthesized bioidentical estradiol, and does that distinction matter for my specific situation?
Am I being told the horse-derived option is less natural than a lab-made bioidentical one, when the opposite is true by the ordinary meaning of the word?

Questions for your doctor

Which specific estrogen product are you recommending, conjugated equine estrogens or estradiol, and why?
Does the choice between these two matter for my specific risk profile, like clotting or breast cancer risk?
Is there a meaningful clinical reason to choose one over the other for me, beyond the word natural?
What does the evidence actually show for the specific product you're recommending, rather than for hormones in general?

Questions with no answer yet

Does it matter clinically whether a woman's estrogen came from a mare's urine or a laboratory synthesis, once the actual molecule and dose are accounted for?

Partly studied

What is known: The original large trial found conjugated equine estrogens alone associated with lower breast cancer incidence and mortality than placebo, while conjugated equine estrogens plus medroxyprogesterone acetate was associated with higher incidence; this is the cleanest available separation of the estrogen's own effect from the added progestin's effect within that trial, but the two arms differed in population and were not randomized against each other.

What would test it: A head-to-head randomized trial of conjugated equine estrogens versus estradiol with hard clinical endpoints; the source material states no such trial exists.

Do any of the individual equine-specific components of conjugated equine estrogens, such as equilin, carry different clinical effects on their own, or has the mixture only ever been studied and used as a whole?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The individual equine components of conjugated equine estrogens have never been separately studied for clinical outcomes in women; whether equilin specifically drives any of the observed differences from estradiol, such as the venous thromboembolism risk difference, is unknown.

What would test it: A study isolating individual equine estrogen components and testing them separately against estradiol on the same clinical endpoints.

Sources

1.Pharmacology of estrogens and progestogens: influence of different routes of administration.Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005;8 Suppl 1:3-63. · Review, opinion or mechanism
2.Postmenopausal Hormone Therapy-Local and Systemic: A Pharmacologic Perspective.Smith T, Sahni S, Thacker HL. Postmenopausal hormone therapy, local and systemic: a pharmacologic perspective. J Clin Pharmacol 2020;60(S2):S74-S85. · Review, opinion or mechanism
3.Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.Chlebowski RT, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the WHI randomized clinical trials. JAMA 2020;324(4):369-380. · Randomised trial

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping